Literature DB >> 9325074

Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence.

J M Mascaró1, A España, Z Liu, X Ding, S J Swartz, J A Fairley, L A Diaz.   

Abstract

Pemphigus vulgaris (PV) is a dermatosis mediated by autoantibodies against desmoglein 3 (Dsg3). It was known that intraperitoneal (i.p.) injections of PV IgG and PV F(ab')2, but not of PV Fab, into neonatal mice reproduced the key features of the disease in these animals. It was proposed that crosslinking of antigen by bivalent PV autoantibodies may trigger acantholysis in PV. In the present study, we have used subcutaneous (s.c.) injections of PV IgG and its proteolytic fragments into neonatal mice to test equimolar amounts of these autoantibody fractions. Mice developed clinical and histological features of PV in a dose-dependent manner following a similar time course. PV IgG and Fab fractions induced acantholysis as early as 2 hr after the injection. It was also demonstrated that sc injections of PV Fab were more effective in inducing disease than ip injections. PV autoantibodies may bind an "adhesive site" of Dsg3 and impair its function, thus triggering acantholysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325074     DOI: 10.1006/clin.1997.4408

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  24 in total

Review 1.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

3.  Enrichment of total serum IgG4 in patients with pemphigus.

Authors:  T Funakoshi; L Lunardon; C T Ellebrecht; A R Nagler; C E O'Leary; A S Payne
Journal:  Br J Dermatol       Date:  2012-09-27       Impact factor: 9.302

4.  Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.

Authors:  Michael Jeffrey Cho; Christoph T Ellebrecht; Christoph M Hammers; Eric M Mukherjee; Gopal Sapparapu; Crystal E Boudreaux; Sarah M McDonald; James E Crowe; Aimee S Payne
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

Review 5.  Setting the target for pemphigus vulgaris therapy.

Authors:  Christoph T Ellebrecht; Aimee S Payne
Journal:  JCI Insight       Date:  2017-03-09

6.  Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.

Authors:  Aimee S Payne; Ken Ishii; Stephen Kacir; Chenyan Lin; Hong Li; Yasushi Hanakawa; Kazuyuki Tsunoda; Masayuki Amagai; John R Stanley; Don L Siegel
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

7.  p38MAPK inhibition prevents disease in pemphigus vulgaris mice.

Authors:  Paula Berkowitz; Peiqi Hu; Simon Warren; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

Review 8.  The dual nature of interleukin-10 in pemphigus vulgaris.

Authors:  Michael Jeffrey Cho; Christoph T Ellebrecht; Aimee S Payne
Journal:  Cytokine       Date:  2014-11-22       Impact factor: 3.861

9.  Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin.

Authors:  Paula Berkowitz; Michael Chua; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

Review 10.  Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Authors:  Donna A Culton; Ye Qian; Ning Li; David Rubenstein; Valeria Aoki; Gunter Hans Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.